Prolonged-release fampridine demonstrates rapid and sustained clinically meaningful improvements in walking ability over 24 weeks: MSWS-12 responders in the ENHANCE study

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/24969

Title:	Prolonged-release fampridine demonstrates rapid and sustained clinically meaningful improvements in walking ability over 24 weeks: MSWS-12 responders in the ENHANCE study
Authors:	Hobart, J. Ziemssen, T. FEYS, Peter Linnebank, M. Goodman, A. Farrell, R. Hupperts, R. Englishby, V. McNeill, M. Chang, I. Lima, G.
Issue Date:	2017
Publisher:	WILEY
Source:	EUROPEAN JOURNAL OF NEUROLOGY, 24(SI), p. 434-435 (Art N° EP3162)
Notes:	[Hobart, J.] Plymouth Univ, Plymouth Hosp NHS Trust, Peninsula Sch Med, Plymouth, Devon, England. [Hobart, J.] Plymouth Univ, Plymouth Hosp NHS Trust, Peninsula Sch Dent, Plymouth, Devon, England. [Ziemssen, T.] Univ Clin Dresden, Dresden, Germany. [Feys, P.] Hasselt Univ, BIOMED REVAL, Diepenbeek, Belgium. [Linnebank, M.] Univ Hosp Witten Herdecke, Witten, Germany. [Goodman, A.] Univ Rochester, Sch Med & Dent, Rochester, NY USA. [Farrell, R.] Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, London, England. [Hupperts, R.] Maastricht Univ, Zuyderland Med Ctr Sittard, Maastricht, Netherlands. [Englishby, V.; McNeill, M.] Biogen, Maidenhead, Berks, England. [Chang, I.; Lima, G.] Biogen, Cambridge, MA USA.
Keywords:	Clinical Neurology; Neurosciences
Document URI:	http://hdl.handle.net/1942/24969
ISSN:	1351-5101
e-ISSN:	1468-1331
ISI #:	000405530100729
Category:	M
Type:	Journal Contribution
Appears in Collections:	Research publications

File	Description	Size	Format
EP3162.pdf	Published version	264.13 kB	Adobe PDF	View/Open

1

checked on May 2, 2024

18

checked on Sep 7, 2022

4

checked on Sep 7, 2022

Check